Should the definition of ‘material events’ for listed companies for the purpose of making timely stock exchange disclosures, ...

Since announcing its first stock repurchase program on July 20, 2022, through the completion of the fourth stock repurchase program, the Company has repurchased 6,659,303 shares, or 23.3% of its ...

While it may feel like there are two Americas right now, nonprofit leaders working on the front lines of our most pressing societal problems have a unique opportunity to reinforce the strength of our ...

Mullen Automotive, Inc. (NASDAQ: MULN) ("Mullen" or the "Company"), an electric vehicle ("EV") manufacturer, announces today its Class 1 EV ...

For the AUSD Board of Governors, the three leading candidates for the three open seats, Meleah Hall and incumbents Heather ...

This new statutory scheme seeks to establish “a mandatory minimum set of requirements for all such contracts” while furthering the Nevada State Contractors Board ... unless the change order sets forth ...

The user of the website is referred to as "you" and "your". By posting on our share chat boards you are agreeing to the following: If you are going to post non-English, please also post an English ...

The user of the website is referred to as "you" and "your". By posting on our share chat boards you are agreeing to the following: If you are going to post non-English, please also post an English ...

Whether you’re looking for the perfect toy, craft project, or other treat, this list is full of tested and loved Christmas ...

The start of the Fed's easing cycle appeared to give small business owners a dose of optimism in October, while expectations surrounding November's election also likely played a role. The NFIB Small ...

Since AI technologies are driving a paradigm shift across sectors, companies leveraging them will continue to see share prices grow in the long run. Since 2008, the U.S. stock market has demonstrated ...

NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic ...